SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 1 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,814 | -82.1% | 3,311 | -72.5% | 0.00% | -100.0% |
Q2 2023 | $71,776 | +448500.0% | 12,043 | +150.1% | 0.00% | +100.0% |
Q1 2023 | $16 | +220.0% | 4,815 | +225.8% | 0.00% | – |
Q4 2022 | $5 | -100.0% | 1,478 | -94.7% | 0.00% | -100.0% |
Q3 2022 | $166,000 | +80.4% | 27,648 | +92.5% | 0.00% | +50.0% |
Q2 2022 | $92,000 | +43.8% | 14,364 | +84.9% | 0.00% | +100.0% |
Q1 2022 | $64,000 | -44.3% | 7,770 | +5.1% | 0.00% | -50.0% |
Q4 2021 | $115,000 | +0.9% | 7,394 | +45.7% | 0.00% | -33.3% |
Q3 2021 | $114,000 | +67.6% | 5,075 | +46.4% | 0.00% | +50.0% |
Q2 2021 | $68,000 | +423.1% | 3,466 | +766.5% | 0.00% | – |
Q1 2021 | $13,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |